3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Classical hematology
1
Conditions
Neutropenia
1
Neoplasms
1
Hematologic Neoplasms
1
Fever
1
Febrile Neutropenia
1
Interventions
Epoetin Alfa
8
ferric carboxymaltose
6
epoetin beta
6
Meropenem
6
Ceftazidime
5
Vancomycin
4
Darbepoetin alfa
4
apixaban
3
Enoxaparin
3
Ciprofloxacin
3
Cefepime
3
iron isomaltoside 1000
2
ferrous sulfate
2
ferrous fumarate
2
Teicoplanin
2
Radiotherapy
2
Levofloxacin
2
Filgrastim
2
Dalteparin
2
Cholecalciferol
2
Aspirin
2
Amikacin
2
sotorasib
1
posaconazole
1
ferrous succinate
1
ferric gluconate
1
eltrombopag
1
ceftolozane, tazobactam drug combination
1
Vitamin B 12
1
Vaccination
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Cilastatin, Imipenem Drug Combination
×
Classical hematology
×
Clear all
NCT02149329
2019-09-25
SHORT
Amsterdam UMC, location VUmc
Phase 4
Completed
276 enrolled